Following Mylan’s lead, Amneal Pharmaceuticals (NYSE:AMRX) will ramp up production
of malaria drug hydroxychloroquine for use in treating COVID-19
sufferers. It expects to produce ~20M tablets by mid-April. Shipments
are already underway.
https://seekingalpha.com/news/3553951-amneal-to-ramp-up-production-of-malaria-drug-for-coronavirus-use
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.